Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Hungry bone syndrome following parathyroidectomy

INTRODUCTION

Hypocalcemia is a common problem after parathyroidectomy or thyroidectomy. The fall in serum calcium is primarily due to functional or relative hypoparathyroidism, leading to reductions in bone reabsorption and increases in bone formation, leading to an increased influx of calcium into bone and, in patients without end-stage renal disease, increased calcium excretion and decreased intestinal calcium absorption due to reduced parathyroid hormone (PTH)-mediated renal 1,25-dihydroxycholecalciferol (1,25(OH)2D) production. A less frequent contributing factor is acute calcitonin release from the thyroid gland.

The hypocalcemia is generally transient because the degree of bone disease is typically mild and normal parathyroid tissue recovers function quickly (usually within one week), even after long-term suppression.

In some cases, however, the postoperative hypocalcemia is severe and prolonged, despite normal or even elevated levels of PTH. This phenomenon, called the hungry bone syndrome, most often occurs in patients who have developed bone disease preoperatively due to a chronic increase in bone resorption induced by high levels of PTH (osteitis fibrosa) [1,2]. The underlying hyperparathyroidism can either be primary or secondary due to end-stage renal disease. In addition to parathyroidectomy, a less severe hypocalcemic syndrome can occur in patients with end-stage renal disease who are treated with calcimimetics, which reduce PTH secretion by modulating the calcium-sensing receptor in the parathyroid glands [3]. (See "Indications for parathyroidectomy in end-stage renal disease".)

In addition to reduced serum calcium, reduced serum phosphate and increased serum potassium levels may be observed in hungry bone syndrome. The decreased serum calcium and phosphate and increased potassium likely reflect increased bone influx and efflux, respectively. (See 'Clinical features' below.)

Hungry bone syndrome has also been described after thyroidectomy in patients with hyperthyroidism [4,5]. In such patients, the preoperative bone disease is due to high bone turnover induced by excess thyroid hormone. A less common cause is estrogen therapy in patients with metastatic prostate cancer [6].

              

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Nov 23, 2012.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Albright F, Reifenstein EC Jr. The parathyroid glands and metabolic bone disease, Williams & Wilkins, Baltimore 1948.
  2. Brasier AR, Nussbaum SR. Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 1988; 84:654.
  3. Goodman WG, Frazao JM, Goodkin DA, et al. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int 2000; 58:436.
  4. DENT CE, HARPER CM. Hypoparathyroid tetany (following thyroidectomy) apparently resistant to vitamin D. Proc R Soc Med 1958; 51:489.
  5. Jones RM, Davidson CM. Thyrotoxicosis and the hungry bone syndrome: a cause of postoperative tetany. J R Coll Surg Edinb 1987; 32:24.
  6. Vogelgesang SA, McMillin JM. Hypocalcemia associated with estrogen therapy for metastatic adenocarcinoma of the prostate. J Urol 1988; 140:1025.
  7. Jofré R, López Gómez JM, Menárguez J, et al. Parathyroidectomy: whom and when? Kidney Int Suppl 2003; :S97.
  8. Felsenfeld AJ, Gutman RA, Llach F, et al. Postparathyroidectomy hypocalcemia as an accurate indicator of preparathyroidectomy bone histology in the uremic patient. Miner Electrolyte Metab 1984; 10:166.
  9. Falko JM, Bush CA, Tzagournis M, Thomas FB. Case report. Congestive heart failure complicating the hungry bone syndrome. Am J Med Sci 1976; 271:85.
  10. Shinoda T, Aizawa T, Shirota T, et al. Exacerbation of latent heart failure by mild hypocalcemia after parathyroidectomy in a long-term hemodialysis patient. Nephron 1992; 60:482.
  11. Benz RL, Schleifer CR, Teehan BP, et al. Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Perit Dial Int 1989; 9:285.
  12. Cruz DN, Perazella MA. Biochemical aberrations in a dialysis patient following parathyroidectomy. Am J Kidney Dis 1997; 29:759.
  13. Shpitz B, Korzets Z, Dinbar A, et al. Immediate postoperative management of parathyroidectomized hemodialysis patients. Dial Transplant 1986; 15:507.
  14. Tohme JF, Bilezikian JP. Diagnosis and treatment of hypocalcemic emergencies. The Endocrinologist 1996; 6:10.
  15. Clair F, Leenhardt L, Bourdeau A, et al. Effect of calcitriol in the control of plasma calcium after parathyroidectomy. A placebo-controlled, double-blind study in chronic hemodialysis patients. Nephron 1987; 46:18.
  16. Lee IT, Sheu WH, Tu ST, et al. Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. J Bone Miner Metab 2006; 24:255.
  17. Kumar A, Ralston SH. Bisphosphonates prevent the hungry bone syndrome. Nephron 1996; 74:729.
  18. Davenport A, Stearns MP. Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome. Nephrology (Carlton) 2007; 12:386.